Akebia Therapeutics (AKBA) Shareholder Nantahala Capital Management Has Increased Holding; As Flowers Foods (FLO) Market Value Declined, Wellington Shields & Company Has Boosted Its Position by $137.31 Million

May 31, 2018 - By Ash

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Logo

Wellington Shields & Company increased its stake in Flowers Foods Inc (FLO) by 4675.67% based on its latest 2018Q1 regulatory filing with the SEC. Wellington Shields & Company bought 6.54M shares as the company’s stock declined 5.61% with the market. The institutional investor held 6.68M shares of the consumer non-durables company at the end of 2018Q1, valued at $145.99M, up from 139,839 at the end of the previous reported quarter. Wellington Shields & Company who had been investing in Flowers Foods Inc for a number of months, seems to be bullish on the $4.37 billion market cap company. The stock increased 3.70% or $0.74 during the last trading session, reaching $20.75. About 3.39M shares traded or 164.52% up from the average. Flowers Foods, Inc. (NYSE:FLO) has risen 8.27% since May 31, 2017 and is uptrending. It has underperformed by 4.30% the S&P500.

Wilmot B. Harkey increased its stake in Akebia Therapeutics Inc (AKBA) by 75.1% based on its latest 2018Q1 regulatory filing with the SEC. Nantahala Capital Management Llc bought 1.45 million shares as the company’s stock declined 31.79% with the market. The hedge fund run by Wilmot B. Harkey held 3.39M shares of the health care company at the end of 2018Q1, valued at $32.27M, up from 1.93 million at the end of the previous reported quarter. Nantahala Capital Management Llc who had been investing in Akebia Therapeutics Inc for a number of months, seems to be bullish on the $562.01M market cap company. The stock decreased 2.66% or $0.27 during the last trading session, reaching $9.88. About 443,107 shares traded. Akebia Therapeutics, Inc. (NASDAQ:AKBA) has declined 25.63% since May 31, 2017 and is downtrending. It has underperformed by 38.20% the S&P500.

Among 14 analysts covering Flowers Foods (NYSE:FLO), 6 have Buy rating, 0 Sell and 8 Hold. Therefore 43% are positive. Flowers Foods had 37 analyst reports since September 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by KeyBanc Capital Markets given on Tuesday, March 27. KeyBanc Capital Markets initiated the stock with “Sector Weight” rating in Thursday, May 26 report. The firm has “Buy” rating by SunTrust given on Tuesday, September 22. The stock of Flowers Foods, Inc. (NYSE:FLO) has “Buy” rating given on Monday, September 21 by Deutsche Bank. BMO Capital Markets maintained Flowers Foods, Inc. (NYSE:FLO) rating on Wednesday, November 15. BMO Capital Markets has “Market Perform” rating and $20 target. Deutsche Bank downgraded Flowers Foods, Inc. (NYSE:FLO) rating on Friday, February 12. Deutsche Bank has “Hold” rating and $18 target. The firm earned “Neutral” rating on Thursday, February 11 by Suntrust Robinson. BMO Capital Markets downgraded Flowers Foods, Inc. (NYSE:FLO) on Friday, February 12 to “Market Perform” rating. The stock of Flowers Foods, Inc. (NYSE:FLO) earned “Buy” rating by Gabelli on Wednesday, February 15. Stephens downgraded the stock to “Equal-Weight” rating in Thursday, February 11 report.

Since March 27, 2018, it had 0 insider purchases, and 1 sale for $221,680 activity.

More recent Flowers Foods, Inc. (NYSE:FLO) news were published by: Nasdaq.com which released: “5 Notable Dividend Increases From the Past Week — Including Flowers Foods, Inc.” on May 29, 2018. Also Seekingalpha.com published the news titled: “Small Cap Dividend Spotlight: Flowers Foods” on May 10, 2018. Seekingalpha.com‘s news article titled: “Flowers Foods’ (FLO) CEO Allen Shiver on Q1 2018 Results – Earnings Call Transcript” with publication date: May 17, 2018 was also an interesting one.

Investors sentiment decreased to 0.91 in 2018 Q1. Its down 0.29, from 1.2 in 2017Q4. It worsened, as 36 investors sold FLO shares while 99 reduced holdings. 45 funds opened positions while 78 raised stakes. 140.96 million shares or 9.91% more from 128.25 million shares in 2017Q4 were reported. Vantage Investment Advsrs Ltd Limited Liability Company, Pennsylvania-based fund reported 500 shares. Ameriprise Financial Incorporated invested 0.01% of its portfolio in Flowers Foods, Inc. (NYSE:FLO). Vident Inv Advisory Limited Liability Corporation holds 53,208 shares. Stone Ridge Asset Management Limited Liability Corp holds 112,315 shares or 0.14% of its portfolio. Metropolitan Life Ny reported 53,236 shares. Royal Bancorporation Of Canada holds 0.01% or 564,068 shares in its portfolio. Sg Americas Securities Ltd Liability Company holds 51,243 shares. 15,249 are held by Envestnet Asset Management Incorporated. Moreover, State Board Of Administration Of Florida Retirement has 0.02% invested in Flowers Foods, Inc. (NYSE:FLO). Prudential Financial Incorporated holds 0.02% of its portfolio in Flowers Foods, Inc. (NYSE:FLO) for 635,506 shares. Verition Fund Mngmt Ltd Co has invested 0.06% in Flowers Foods, Inc. (NYSE:FLO). Bb&T Corporation owns 1.19M shares or 0.5% of their US portfolio. Grassi Management invested 0.04% of its portfolio in Flowers Foods, Inc. (NYSE:FLO). Robeco Institutional Asset Bv stated it has 12,889 shares. Mckinley Carter Wealth has 4,733 shares.

Another recent and important Akebia Therapeutics, Inc. (NASDAQ:AKBA) news was published by Businesswire.com which published an article titled: “Akebia Therapeutics to Present at Upcoming Investor Conference” on May 15, 2018.

Investors sentiment increased to 1.9 in Q1 2018. Its up 0.27, from 1.63 in 2017Q4. It increased, as 14 investors sold AKBA shares while 28 reduced holdings. 37 funds opened positions while 43 raised stakes. 39.14 million shares or 29.30% more from 30.27 million shares in 2017Q4 were reported. Tudor Invest Et Al has invested 0.01% of its portfolio in Akebia Therapeutics, Inc. (NASDAQ:AKBA). Point72 Asset Management LP stated it has 194,150 shares or 0.01% of all its holdings. Texas-based Hbk Invs Limited Partnership has invested 0.01% in Akebia Therapeutics, Inc. (NASDAQ:AKBA). Voya Mgmt Ltd Com owns 0% invested in Akebia Therapeutics, Inc. (NASDAQ:AKBA) for 20,308 shares. Sterling Cap Mgmt Lc accumulated 32,425 shares. Envestnet Asset Mgmt Inc invested in 2,242 shares or 0% of the stock. Price T Rowe Inc Md holds 0% or 22,186 shares. Metropolitan Life Ins Com New York reported 14,181 shares. Ubs Asset Americas owns 17,800 shares. Citigroup stated it has 0% in Akebia Therapeutics, Inc. (NASDAQ:AKBA). Verition Fund Mgmt Ltd Liability Co holds 13,739 shares. Credit Suisse Ag accumulated 52,988 shares. Jpmorgan Chase holds 0% of its portfolio in Akebia Therapeutics, Inc. (NASDAQ:AKBA) for 271,673 shares. Tiaa Cref Investment Mgmt Lc reported 0% in Akebia Therapeutics, Inc. (NASDAQ:AKBA). Ameritas Investment Prns Inc holds 3,813 shares.

Among 11 analysts covering Akebia Therapeutics Inc (NASDAQ:AKBA), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. Akebia Therapeutics Inc had 25 analyst reports since August 13, 2015 according to SRatingsIntel. Mizuho maintained the shares of AKBA in report on Wednesday, March 7 with “Buy” rating. The stock of Akebia Therapeutics, Inc. (NASDAQ:AKBA) has “Neutral” rating given on Thursday, January 21 by Credit Suisse. The company was initiated on Monday, December 18 by Piper Jaffray. The stock has “Buy” rating by H.C. Wainwright on Tuesday, December 27. The firm has “Buy” rating by Needham given on Tuesday, December 15. The firm has “Buy” rating given on Tuesday, March 15 by H.C. Wainwright. The firm has “Buy” rating given on Wednesday, August 9 by H.C. Wainwright. The stock of Akebia Therapeutics, Inc. (NASDAQ:AKBA) has “Buy” rating given on Monday, July 10 by H.C. Wainwright. The stock of Akebia Therapeutics, Inc. (NASDAQ:AKBA) has “Buy” rating given on Tuesday, December 15 by H.C. Wainwright. Morgan Stanley initiated the shares of AKBA in report on Thursday, August 13 with “Equal Weight” rating.

Since February 15, 2018, it had 0 insider buys, and 1 insider sale for $14,620 activity.

Flowers Foods, Inc. (NYSE:FLO) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>